HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being investigated to treat a wide range of solid…
Former Amadeus President and Southwest Airlines SVP & CIO Join Payment Orchestration Leader to Drive Next Phase of Travel Retailing…
Supply chain planning veteran brings technical expertise, experience scaling go-to-market functions to lead company through next phase of growth WILMINGTON,…
Genesis Magma Racing’s technical leads reflect on the busy first weeks of the GMR-001 Hypercar’s on-track development phase FX Demaison and…
The $2.5 Million in NIH STTR Phase 2 Grant allows NanoNewron to start the IND-enabling program for the NN-840 program…
SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…
September 06, 2025 14:30 ET | Source: BridgeBio Pharma, Inc. - 80% of post-surgical hypoparathyroidism participants achieved concomitant blood and…
Hospitality leader with extensive multi-disciplinary experience to drive Marriott International's South Asia region in the next phase of growth MUMBAI,…
Singapore, Sept. 05, 2025 (GLOBE NEWSWIRE) -- the9bit, an innovative gaming platform backed by The9 Limited (NASDAQ: NCTY), has concluded…
WALTHAM, Mass., Sept. 01, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory…